Pakistan approves Chinese Sinopharm COVID vaccine for emergency use
2021-01-19 04:12
FILE PHOTO A booth displaying a coronavirus disease COVID Human Immunoglobulin for Intravenous Injection from China National Biotec Group CNBG, a unit of stateowned pharmaceutical giant China National Pharmaceutical Group Sinopharm, is seen at the  China International Fair for Trade in Services CIFTIS, following the COVID outbreak, in Beijing, China September , . PhotoAgencies    ISLAMABAD  Pakistan on Monday approved the Chinese Sinopharm COVID vaccine for emergency use, a government statement said. The Drug Regulatory Authority Pakistan DRAP said the vaccine, manufactured by China National Pharmaceutical Group SinoPharm, had been given emergency use approval EUA. The authority had approved AstraZenecas vaccine, developed with Oxford University, for emergency use at the weekend. Pakistans health ministry has said the country was in process of speaking to different vaccine candidates. Reuters